Mikhail Blagosklonny Committed to Finding the Cure to Cancer at Affordable Cost

Mikhail Blagosklonny currently serves as the professor of Oncology at Rosewell Park Cancer Institute which is located in Buffalo, New York. Over the years Blagosklonny has been conducting researches on cancer and some of its therapies. Blagosklonny besides being an academician is also the Editor in Chief of Oncotarget journal and has published a lot of research on the topic of aging. Blagosklonny has contributed a lot in finding better treatment methods for cancer at a relatively lower cost that everyone could afford. One of Blagosklonny major achievements is in the research on the healing properties of Rapamycin. Rapamycin is a drug that plays a very critical role when it comes to organ transplant. The drug which is also known as Sirolimus helps prevent organ rejection during an organ transplant.

Rapamycin besides is used in coronary stents coating and also in the treatment of a rare lung disease known as Lymphangioleiomyomatosis (LAM). Of particular interest to Blagosklonny is Rapamycin ability to treating cancer.Rapamycin was first discovered in 1972 and was then used as an anti-fungal agent. On further testing, it was realized that the drug had some tremendous immunosuppressive and antiproliferative properties. These amazing properties of the drug made physicians abandon the use of the drug as an anti-fungal agent. Rapamycin has turned out to be one of the best drugs due to its immunosuppressant properties. These properties have made it possible for surgeons to carry out organ transplant without the fear of rejections. Prior to the discovery of Rapamycin in cases of organ rejection doctors used to prescribe anti-rejection drugs or calcineurin inhibitors. However, these drugs had some adverse effects on the kidney once used over a long period of time. This is where Rapamycin comes into play as the drug when used as an immunosuppressive drug during transplant has little to no effect towards the kidney.

Rapamycin due to its incredible healing properties is used in the treatment of diseases such as hemolytic-uremic syndrome, Lymphangioleiomyomatosis (LAM), coronary stent coating, Tuberous Sclerosis Complex (TSC), Facial angiofibromas and cancer.Mikhail Blagosklonny besides being a professor and an editor is also a philanthropist. Part of his philanthropic activities is in making sure that cancer patients around the world get the best type of treatment regardless of their social economic status. To achieve this goal Blagosklonny is conducting extensive research on cancer and aging and more specifically the relationship between the two as cancer tends to attack individuals who have reached a certain age. Blagosklonny has made a positive mark in the field of oncology and has been a source of inspiration to his peers and students who are aiming to advance research in oncology.Mikhail Blagosklonny published articles on different topics especially in regards to cancer and aging has earned him recognition in the medical field and on impactjournals.com. Mikhail Blagosklonny goal is not only in finding the cure for cancer disease but also finding a treatment method that is less painful and affordable as opposed to the current excruciating and expensive treatment method that only a few wealthy people can afford.

Norman Pattiz Revolutionizes the Podcast Industry

For the longest time, PodcastOne has led the podcast industry in revolutionary technology and features. For years, the company’s wanted to bring something new and exciting to the world of podcast. That dream was realized recently when the company announced its new mobile app.

This app comes with many new features that are first-time options for podcast listeners. Not only will listeners have hundreds of shows to listen to, some of them even have recorded video to go along with the audio. In some cases, the video is filmed in virtual reality. That’s what’s got most people excited about this new app.

The virtual reality brings whole other element to the podcast world. It was important to Norman Pattiz, founder of PodcastOne, that the virtual reality be as real as possible. To ensure the highest quality, PodcastOne partnered with Mandt VR, one of the best in the virtual reality business.

Mandt VR began setting up the newest equipment as soon as possible. They rigged numerous studios in every major PodcastOne building. They even set mobile equipment so that hosts can travel and continuous shoot VR footage. To date, the two companies have filmed over 1,000 VR videos.

After the announcement, Neil Mandt, founder of Mandt VR, talked about working with Norman Pattiz. He considers Pattiz to be a media pioneer (http://www.hsacouncil.org/norman-pattiz/). He got to watch Pattiz persuade his company to try something new that no one else would’ve done. Mandt actually praises Pattiz for launching innovative features and embracing new technology.

PodcastOne as a company adopted numerous first-time business methodsb (http://dashconference.com/speakers/norman-pattiz/). When podcasts first became popular, PodcastOne studied how viable advertising on podcast shows would be. When they discovered that advertising on podcasts had a positive effect, they adopted the first advertising-based business model for a podcast company.

Before he launched PodcastOne, Pattiz founded Westwood One, the largest provider of programming in the broadcast industry. Westwood supplies several radio stations with news, sports, entertainment, talk, and traffic shows. Westwood also worked with numerous big-name media outlets like CBS News, CNN radio, NCAA Basketball, and The Super Bowl.

Even before Westwood One and PodcastOne, Pattiz’s career was astonishing. He created the biggest network in the Arabic language that broadcasts in several countries. He also served as a governor on the Broadcasting Board of Governors for two presidents.


A Closer Look at Daniel Mark Harrison

Daniel Mark Harrison is the co-founder and managing partner of Monkey Capital. Although the name sounds boyish at best, it’s by far one of the most successful companies of its kind.

Earlier this August, Mr. Daniel Mark Harrison had secured the domain name of monkey.com for a whopping $500,000. An unnamed company in the United States had held the trademark since 1994 – talk about prudent on that mystery investor’s behalf. Mr. Harrison had provided $400,000 cash and $100,000 United States Dollars’ worth of COEVAL, Monkey Capital’s cryptocurrency. Despite the purchase price, Mr. Harrison said in a press release that “The price of $500,000 was in truth a bargain for what [it] will deliver us.”

Huffington Post had mentioned Monkey Capital and Mr. Daniel Mark Harrison no longer than a few months ago, titling the decentralized hedge fund as a “billion dollar baboon,” certain a compliment for Mr. Harrison and his innovative creation.

Despite being so young, Mr. Daniel Mark Harrison has put in a great deal of work throughout his already-bustling career. He started his career off at the University of Oxford with a bachelor’s degree in Theology. Harrison then enrolled at the BI Norwegian Business School to earn an MBA in just one year, even though the program was scheduled to require two years of instruction. Just one year after he topped his resume off with that MBA in 2006, he worked towards a master’s of journalism with a concentration in business in 2007.

Mr. Harrison founded Daniel Mark Harrison & Company in October of 2015, controlling his own assets and those of his closest family members. It’s currently operated out of Singapore, with additional branches in Bangkok and Hong Kong.

Daniel Mark Harrison is as much of a writer as he is a cryptocurrency and financial markets expert, having authored two full-length books, titled Butterflies: The Strange Metamorphosis of Fact and Fiction in Today’s World and The Millennial Reincarnation. He wrote for and starred on several videos on TheStreet for three years before writing for The Motley Fool. He’s since worked for Marx Rand and CoinSpeaker, both as Editor-in-Chief.